| |
|
|
|
Pacific Biosciences  
|
|
14.95 0.58 (0.04%) |
10-19 16:00 |
|
Open: |
14.49 |
Pre close: |
14.37 |
Target:
|
17.54 
|
|
High: |
15.02 |
Low: |
14.4019 |
Resistance:
|
15.02
17.54
|
|
Volume: |
4,960,342 |
Market Cap: |
2642M |
Support:
|
10.13
7.10
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
14.31
|
MACD |
MACD(12,26):
|
1.82 |
|
MA(20): |
11.75 |
Signal(12,26,9): |
1.65 |
|
MA(100): |
6.22 |
Stochastic Oscillator |
%K(14,3):
|
97.68 |
|
MA(250): |
5.00 |
%D(3): |
97.70 |
|
Average Volume(K) |
3-Month: |
385611
|
52-Week |
High:
|
15.02 |
|
10-Days: |
566014 |
Low: |
2.20 |
|
RSI |
RSI(14):
|
86.08 |
Change(%): |
183.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.330 |
Return on Equity (ttm) |
-87.1 |
Shares Out. (M) |
176.75 |
|
EPS Est. Current Year |
-0.890 |
Return on Assets (ttm) |
-28.7 |
Shares Float (M) |
151.36 |
|
EPS Est. Next Year |
-0.640 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.33 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-30.6 |
% Held by Institutions |
87.94 |
|
Forward EPS |
-0.550 |
Gross Profit (p.s.) |
0.196 |
Shares Short (K) |
17230 |
|
Book Value (p.s.) |
0.270 |
EBITDA (p.s.) |
-0.460 |
P/E |
-45.30 |
|
Sales Per Share |
0.467 |
Qtrly Earnings Growth |
0.00 |
P/BV |
55.37 |
|
Profit Margin |
-61.85 |
Operating Cash Flow
(M) |
16.13 |
P/S |
32.02 |
|
Operating Margin |
-106.84 |
Levered Free Cash Flow
(M) |
65.42 |
P/CF |
163.82 |
|
|
|
|
|
|
